Notícias

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the coronavirus disease 2019 (COVID-19), has caused more than...

Our understanding of the severe acute respiratory syndrome coronavirus 2 has evolved since the first reported cases in December 2019,...

Reverse vaccinology is an evolving approach for improving vaccine effectiveness and minimizing adverse responses by limiting immunizations to critical epitopes....

Coronavirus disease 2019 (Covid-19), caused by novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), has come to the fore in Wuhan,...

The efficacy of convalescent plasma for coronavirus disease 2019 (COVID-19) is unclear. Although most randomized controlled trials have shown negative...

By July 14, 2021, 81·3 % of adults (aged ≥18 years) in Chile had received a first SARS-CoV-2 vaccine and...

COVID-19 is caused by a novel coronavirus, the severe acute respiratory syndrome coronavirus (CoV)-2 (SARS-CoV-2). The virus is responsible for...

As expected, several new variants of Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2) emerged and have been detected around the world throughout...

We and others have previously demonstrated that the endothelium is a primary target of the severe acute respiratory syndrome coronavirus...

While recent literature has shown the efficacy of the SARS-CoV-2 vaccine in preventing infection, it’s impact on need for emergency...

A FACTO n° 66 aborda o tema inovação. Em sua Matéria Política, destaca as
dificuldades estruturais do Brasil na...

There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the...